Hosted on MSN10mon
FDA grants approval for Alexion’s NMOSD treatment
The US Food and Drug Administration (FDA) has approved Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab-cwvz) to treat adults with anti-aquaporin-4 (AQP4) antibody-positive (Ab+ ...
labmate-online.com7d
£500,000 grant funds cutting-edge microscopy for dementia research
Aston Institute for Membrane Excellence (AIME) has been awarded a £500,000 grant from the Wolfson Foundation to acquire an ultrafast spinning disc confocal microscope, enhancing research into ...